Immediate Impact

14 by Nobel laureates 39 from Science/Nature 66 standout
Sub-graph 1 of 22

Citing Papers

Efficacy and safety of the muscarinic receptor agonist KarXT (xanomeline–trospium) in schizophrenia (EMERGENT-2) in the USA: results from a randomised, double-blind, placebo-controlled, flexible-dose phase 3 trial
2023 Standout
Muscarinic Cholinergic Receptor Agonist and Peripheral Antagonist for Schizophrenia
2021 Standout

Works of Frank P. Bymaster being referenced

Towards a muscarinic hypothesis of schizophrenia
2006
Effects of Xanomeline, a Selective Muscarinic Receptor Agonist, on Cognitive Function and Behavioral Symptoms in Alzheimer Disease
1997 Standout
and 3 more

Author Peers

Author Last Decade Papers Cites
Frank P. Bymaster 6575 5006 3099 141 12.6k
Claude de Montigny 8067 4607 2940 154 11.9k
Elliott Richelson 6822 6808 2016 288 14.2k
Alan Frazer 4756 2967 1699 206 10.1k
C. Anthony Altar 7745 3524 1235 115 12.3k
Ángel Pazos 7283 4157 2013 167 10.6k
Astrid Nehlig 4762 2386 2333 226 11.5k
Francesc Artigas 9415 4596 3452 273 14.3k
Mike Briley 4671 2688 1885 117 10.6k
Glen B. Baker 4725 3255 2037 423 13.2k
Trevor Sharp 11260 5479 1838 261 16.0k

All Works

Loading papers...

Rankless by CCL
2026